Publications by Center Staff

Cerebral Flow Velocities During Daily Activities Depend on Blood Pressure in Patients with Chronic Ischemic Infarction
2010

Novak V, Hu K, Desrochers L, Novak P, Caplan L, Lipsitz L and Magdy SH (2010). Cerebral flow velocities during daily activities depend on blood pressure in patients with chronic ischemic infarction. Stroke; 41: 61-67.  PMC-In Process.

Cognitive Behavior Therapy for Patients with Parkinson's Disease and Comorbid Major Depressive Disorder
2010

Farabaugh AH, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, PetersenT, Pava J and Alpert JE (2010).   Cognitive behavior therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics. In Press.

Effects of Simvastatin on Cholesterol Metabolism and Alzheimer’s Disease Biomarkers
2010

Serrano-Pozo A, Vega GL, Dieter L, Locascio JJ, Tennis MK, Deng A, Atri A, Hyman BT, Irizarry MC and Growdon JH (2010). Effects of simvastatin on cholesterol metabolism and Alzheimer’s disease biomarkers. Alzheimer Dis Assoc Disord. Accepted for publication. PMC-In Process.

Functional Alterations in Memory Networks in Early Alzheimer's Disease
2010

Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, Laviolette PS, Vitolo OV, Hedden T, Becker JA, Rentz DM, Selkoe DJ and Johnson KA (2010). Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med; 2010 Jan 13. Epub ahead of print. PMC-In Process.

The Central Nervous System
2010

Frosch M, Anthony D and DeGirolami U (2010). The Central Nervous System. Robbins and Cotran's Pathologic Basis of Disease, Professional Edition, 8th Edition. V Kumar, A Abbas, N Fausto and J Aster (Eds.). Philadelphia, PA: Elsevier Saunders.

Trifulsal Reduces Dense-Core Plaque Load, Associated Axonal Alterations and Inflammatory Changes, and Rescues Cognition in a Transgenic Mouse Model of Alzheimer's Disease
2010

Coma M, Sereno L, Da Rocha-Souto B, Scotton TC, Espana J, Sanchez MB, Rodriguez M, Agullo J, Guardia-Laguarta C, Garcia-Alloza M, Clarimon J, Borrelli LA, Lleo A, Bacskai BJ, Saura CA and Hyman BT (2010). Trifulsal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease.

Variation in Blood Pressure is associated with White Matter Microstructure but not Cognition in African Americans
2010

Leritz EC, Salat DH, Milberg WP, Chapman CE, Grande LJ, Rudolph JL, Fischl B, Schnyer DM, Barber CE, Lipsitz L and McGlinchey RE (2010). Variation in blood pressure is associated with white matter microstructure but not cognition in African Americans. Neuropsychology. In Press. PMC-In Process.

A Phase 2 Multiple Ascending Dose Trial of Bapineuzumab in Mild to Moderate Alzheimer Disease
2009

Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, Sabbagh M, Honig LS, Doody R, van Dyck CH, Mulnard R, Barakos J, Gregg KM, Liu E, Lieberburg I, Schenk D, Black R, Grundman M and Bapineuzumab 201 Clinical Trial Investigators (2009). A phase 2 multiple ascending dose trial of Bapineuzumab in mild to moderate Alzheimer disease. Neurology; 73:  2052-2053. PMCID:  2790221.

A Reporter of Local Dendritic Translation Shows Plaque Related Loss of Neural System Function in APP Transgenic Mice
2009

Meyer-Luehmann M, Mielke M, Spires-Jones T, Stoothoff W, Jones P, Bacskai B and Hyman B (2009). A reporter of local dendritic translation shows plaque related loss of neural system function in APP transgenic mice.  J Neurosci; 29: 12636-40.

A Single Dose of Passive Immunotherapy has Extended Benefits on Synapses and Neurites in an Alzheimer’s Disease Mouse Model
2009

Rozkalne A, Spires-Jones TL, Stern EA and Hyman BT (2009). A single dose of passive immunotherapy has extended benefits on synapses and neurites in an Alzheimer’s disease mouse model. Brain Res; 1280: 178-85. PMCID:  2709850.